Name | 2-[[3-(4-methoxyphenyl)-4-oxo-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]sulfanyl]acetonitrile |
---|---|
Synonyms |
{[3-(4-Methoxyphenyl)-4-oxo-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetonitrile
Acetonitrile, 2-[[3,4,5,6,7,8-hexahydro-3-(4-methoxyphenyl)-4-oxo[1]benzothieno[2,3-d]pyrimidin-2-yl]thio]- Necrostatin-5 Nec-5 |
Description | Necrostatin-5 (Nec-5) is a potent necroptosis inhibitor with an EC50 value of 0.24 µM. Necrostatin-5 also is a RIP1 inhibitor. Necrostatin-5 shows cardioprotective effects[1][2][3]. |
---|---|
Related Catalog | |
Target |
RIPK1 necroptosis:0.24 μM (EC50) |
In Vitro | Necrostatin-5 (1、5、10、50、100 µM) 以剂量依赖性方式抑制 LDH 释放[3]。 Necrostatin-5 (100 µM) 保护 MH-S 细胞免受 S. aureus, Listeria monocytogenes, S. pneumoniae, uropathogenic Escherichia coli (UPEC) 的攻击,并防止肺炎球菌溶血素引起的死亡[3]。 |
In Vivo | Necrostatin-5 (2.46 mg/kg;腹腔注射) 对大鼠离体心脏模型显示心脏保护作用[2]。 Animal Model: 200-300 g, male Wistar rats[2] Dosage: 2.46 mg/kg Administration: I.p.; 60 min before experiment Result: Reduced the infarction zone caused by 30-min global ischemia and 120-min reperfusion. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 640.4±65.0 °C at 760 mmHg |
Molecular Formula | C19H17N3O2S2 |
Molecular Weight | 383.49 |
Flash Point | 341.1±34.3 °C |
Exact Mass | 383.076202 |
PSA | 121.45000 |
LogP | 4.01 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |
Index of Refraction | 1.724 |
Storage condition | -20°C |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H319-H413 |
Precautionary Statements | P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi |
RIDADR | NONH for all modes of transport |